MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 05-23-2026
HEXO Corp. ROE Ratio 2011-2026 | HEXO
Annual ROE Ratio HEXO Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -342.25 | -15.68 | -98.17 | -8.83 | -7.23 | -38.33 | -43.08 | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -7.23 | -342.25 | -79.08 |
Quarterly ROE Ratio HEXO Corp.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -456.1 | -464.92 | -122.67 | -122.67 | -122.67 | -129.91 | -114.23 | -114.23 | -114.23 | -98.17 | - | - | - | -8.83 | - | - | - | -7.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -7.23 | -464.92 | -156.32 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-76.05 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-5.67 | $ 5.59 | -0.27 % | $ 83 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-53.8 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-83.89 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-91.16 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-0.27 | $ 2.66 | -0.93 % | $ 1.02 B |  Canada |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
-9.8 | $ 39.34 | 4.5 % | $ 1.45 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
12.33 | $ 2.38 | 1.71 % | $ 302 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 22.84 | -0.65 % | $ 1.06 B | USA |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.02 | 2.01 % | $ 110 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 1.15 | 5.4 % | $ 1.43 M | USA |
 |
Aurora Cannabis
ACB
|
0.26 | $ 3.17 | 4.11 % | $ 174 M | Canada |
 |
Solid Biosciences
SLDB
|
-96.84 | $ 7.39 | 3.5 % | $ 647 M | USA |
 |
Jupiter Wellness
JUPW
|
-194.84 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-14.85 | $ 1.06 | -0.47 % | $ 101 M | Canada |
 |
Tilray
TLRY
|
-43.81 | $ 5.11 | 2.51 % | $ 3.16 B | Canada |
 |
Evolus
EOLS
|
223.5 | $ 6.66 | -1.04 % | $ 429 M | USA |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.44 | 1.75 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
10.07 | $ 8.35 | 0.36 % | $ 447 M | USA |
 |
cbdMD
YCBD
|
-28.24 | $ 0.7 | 2.06 % | $ 2.82 M | USA |
 |
Veru
VERU
|
-123.97 | $ 3.13 | 4.33 % | $ 45.8 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-34.11 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
-32.33 | $ 23.49 | 0.04 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-420.27 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
-28.34 | $ 5.08 | 0.4 % | $ 1.88 B | Canada |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-66.33 | $ 6.81 | 2.33 % | $ 269 M | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
53.37 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-17.44 | $ 4.31 | 1.89 % | $ 215 M | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
-23.89 | $ 16.42 | -0.39 % | $ 19.2 B | USA |
 |
Zomedica Corp.
ZOM
|
-70.94 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-14.37 | $ 0.65 | 3.92 % | $ 23.4 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.02 | $ 0.74 | -0.15 % | $ 3.18 M |  China |
 |
TherapeuticsMD
TXMD
|
-2.12 | $ 2.29 | 4.09 % | $ 26.5 M | USA |